Global Bone and Mineral Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

Global Bone and Mineral Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsible for adverse changes in bone and mineral metabolism. Increase in serum parathyroid hormone levels due to fall in glomerular filtration rate is an indicator of bone disorder caused by chronic kidney disease. Reduction in kidney function leads to changes in bone mineral homeostasis and in levels of parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and fibroblast growth factor-23 (FGF-23). Disorders of mineral metabolism in chronic kidney disease (CKD) have been associated with higher mortality than anemia and inadequate dialysis.

LPI (LP Information)' newest research report, the “Bone and Mineral Diagnostic Testing Industry Forecast” looks at past sales and reviews total world Bone and Mineral Diagnostic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone and Mineral Diagnostic Testing sales for 2023 through 2029. With Bone and Mineral Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone and Mineral Diagnostic Testing industry.

This Insight Report provides a comprehensive analysis of the global Bone and Mineral Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone and Mineral Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone and Mineral Diagnostic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone and Mineral Diagnostic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone and Mineral Diagnostic Testing.

The global Bone and Mineral Diagnostic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The global bone & mineral market is driven by rise in geriatric population, need for early diagnosis to start treatment at its earliest, and increase in incidence of bone disorders. However, high cost of such tests and limited detection capability & inefficiency hamper the market growth. Development in automation of assay, and growth in public awareness towards personal and healthcare provides opportunities for the market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Bone and Mineral Diagnostic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Instruments
Assays/Consumables

Segmentation by application
Vitamin D Testing
Bone Metabolism

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Diagnostics
bioMérieux
Diasorin
Roche Diagnostic
Siemens Healthcare
Quidel

Please note: The report will take approximately 2 business days to prepare and deliver.